Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...

Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...

THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more standard-of-care regimens.

LIBTAYO demonstrated massive growth ... even as the company has grown two new blockbuster drugs to recover EYLEA's lost ground. As the EYLEA franchise has stabilized, I believe investors are ...

There are several types of medications that can be used to treat MS, including chemotherapy drugs, anti-inflammatories, immunosuppressive drugs, and steroids. In some cases, medications for MS are ...

Of its remaining product sales, standouts included cancer drug Libtayo, with a robust 50% gain to $367 million. The company's collaboration revenue derived from partnerships with Sanofi and Bayer ...

Total revenues increased 10% year over year to $3.79 billion, fueled by increased collaboration revenues from Sanofi SNY for Dupixent, higher Eylea HD and Libtayo sales. Revenues marginally beat ...

In the fourth quarter of 2024, Libtayo grew sales 50% to $367 million, propelling the PD-1 treatment past the blockbuster threshold for the first time. During the full year, the drug's sales reach ...

It can occur with prescription or nonprescription drugs. It can also range from mild to severe. Substance use disorder, formerly known as “drug abuse,” develops when substance use interferes ...

Prescription drugs can be administered in various ways. This includes oral (by mouth), enteral (into the gastrointestinal tract), mucosal (through a mucus membrane), and percutaneous (through the skin ...